Similarly, naringenin inhibits the proliferation and migration of B16F10 and SK-MEL-28 melanoma cells by reducing the phosphorylation of ERK1/2, JNK, and MAPK, thereby exerting anti-melanoma effects [47]. Here, MAPK3 is linked to melanoma.